This new report into the Cosmetic Surgery market provides unique insights into procedures, prices, internet search analytics and investor activity.
Covering cosmetic surgery, non-surgical cosmetic treatment and cosmetic dentistry this study shows that the market has grown little in the past five years. According to the British Association of Aesthetic Plastic Surgeons, the only significant areas of growth in 2017 were in breast augmentation and breast reduction. Typically favoured by younger patients, this speaks of a market which is no longer the reserve of the old and the wealthy.
The report reveals a market where against a backdrop of slow growth, there are areas of real vibrancy. The non-surgical cosmetic treatment market is strong and is expected to be worth more than £3 billion in five years’ time. Whereas private hospitals appear to view cosmetic surgery as a ‘nice to have’, there are specialist providers and clinics who are actively developing business by looking for new ways to engage existing and potential clients.
While cosmetic surgery has lost much of its previous stigma, the influence of social media is a key driver for growth. Price is also a key driver, especially among young women seeking nonsurgical procedures. This is worrying in a market which currently lacks regulation as patients may not fully understand the risks or implications for poor clinical practice. It may take a public health or medical malpractice scandal to trigger much-needed regulatory reform in this area.
The publisher's work shows prices have risen in the past four years. Market leading procedure, breast augmentation, has become 8% more expensive between 2014 and 2018. However, it also suggests that the market is likely to be hit particularly hard if there is an economic downturn as a result of Brexit. What’s more, there is evidence to suggest that overseas travel for cosmetic surgery, especially to Europe, is declining slightly owing to a weaker pound and more aggressive marketing on the part of UK providers.
The report covers cosmetic surgery, non-surgical cosmetic treatment and cosmetic dentistry and shows that the cosmetic surgery market has grown little in the past five years. According to the British Association of Aesthetic Plastic Surgeons, the only significant areas of growth in 2017 were in breast augmentation and breast reduction. Typically favoured by younger patients, this speaks of a market which is no longer the reserve of the old and the wealthy.
The report reveals a market where against a backdrop of slow growth, there are some areas of real vibrancy.
The non-surgical cosmetic treatment market is strong and is expected to be worth more than £3 billion in five years’ time. Whereas private hospitals appear to view cosmetic surgery as a ‘nice to have’, there are specialist providers and clinics who are actively developing business by looking for new ways to engage existing and potential clients. As the report finds, it is no doubt greatly to their benefit that non-surgical treatments frequently lead to full surgical interventions at a later date.
While cosmetic surgery has lost much of its previous stigma, the influence of social media is a key driver for growth. Not only is this about marketing and promotion, but it is a forum for the capturing and sharing of patient experiences, including by celebrities who are increasingly open about the work they have had done.
Price, however, is a key driver, especially among young women seeking non-surgical procedures. This is worrying in a market which currently lacks regulation as patients may not fully understand the risks or implications for poor clinical practice. It may take a public health or medical malpractice scandal to trigger much-needed regulatory reform in this area.
In the cosmetic surgery market, the report shows prices have risen in the past four years. For example, market leading procedure, breast augmentation, has become 8% more expensive between 2014 and 2018.
The report shows that the cosmetic surgery market is likely to be hit particularly hard if there is an economic downturn as a result of Brexit. It suffered between 2009 and 2012, and there is every reason to believe that what is essentially a discretionary spend will fare no better if household budgets are squeezed from spring 2019 onwards. There is evidence to suggest that overseas travel for cosmetic surgery, especially to Europe, is declining slightly owing to a weaker pound and more aggressive marketing on the part of UK providers.
What the report includes
- Procedures
- Market drivers
- Regional trends
- Regulation & standards
- Funding models
- Costs
- Cosmetic surgery tourism
Who is the report for
- C-suite professionals working in cosmetic surgery
- Clinic owners
- Cosmetic surgery service providers
- NHS Trusts involved in, or considering, cosmetic surgery services
- Banks and other financial institutions
- Investors and private equity
- Insurers
- National government policy-makers
- Lawyers
- Policy advisors
- Think tanks
- Management consultants
Table of Contents
LIST OF TABLES
LIST OF FIGURES
EXECUTIVE SUMMARY
COSMETIC SURGERY
1. MARKET
1.1 Definition and history
1.2 The market
1.2.1 UK comparison with global trends
1.2.2 Demand and supply including regional variation
1.3 Funding
1.3.1 Financing cosmetic surgery
1.4 Demand drivers
1.5 Consumer buying behaviour
1.6 The role of the media
1.7 Marketing cosmetic surgery
1.8 Operating and investment models
1.8.1 New market entrants and provider changes
1.9 Key operational statistics and performance measures
1.9.1 Outcome measures
1.10 Demographics
1.11 Cosmetic surgery tourism
1.11.1 European standards on cosmetic surgery
1.11.2 European standards on non-surgical medical procedures
1.11.3 The role of agents, brokers and third-party administrators
1.11.4 The Package Travel Directive
1.11.5 Pricing of cosmetic procedure outside the UK
1.11.6 Insurance for cosmetic surgery in Europe
2. POLITICS AND REGULATION
2.1 Scope of independent acute medical care regulation in England
2.2 The essential standards in England
2.3 Care Quality Commission developments for independent acute hospitals and clinics
2.3.1 The CQC and the cosmetic market
2.4 PHIN and performance data
2.5 The Nuffield Council on Bioethics review 2017
2.5.1 Controls on practitioners 35
2.5.2 Controls over premises
2.5.3 Controls over products
2.5.4 Young people's access to cosmetic procedures
2.5.5 Tackling the wider social context
2.5.6 Advertising and marketing
2.5.7 Discrimination
2.6 The role of the Joint Council for Cosmetic Practitioners (JCCP)
2.7 Other regulatory bodies and those providing oversight 39
2.7.1 The Cosmetic Practice Standards Authority
2.7.2 The Medicines and Healthcare products Regulatory Agency (MHRA)
2.7.3 The Independent Sector Complaints Adjudication Service (ISCAS) 40
2.8 Quality measures and guidance
2.8.1 The role of the NHS
2.8.2 The breast and cosmetic implant registry
2.9 Political oversight and influence
2.10 Quality and good practice guidance
2.11 Training for surgical and non-surgical practice
2.12 Understanding the role of regulation and legislation - the consumer perspective
3. PAYORS
3.1 Price comparison for cosmetic surgery procedures
3.1.1 Teeth whitening
3.1.2 Dental implants
3.1.3 Veneers
3.1.4 Braces
3.1.5 Gum treatment (including laser sculpting)
3.2 Researchconclusions
3.3 Marketing and the role of the media
3.4 Cosmetic dentistry tourism
4. CUSTOMER INSIGHT
4.1 Overview
4.1.1 Demand and growth
4.1.2 Market segmentation and demographics
4.1.3 Influencing factors driving consumer demand
4.1.4 Changing role of marketing, advertising and social influence
4.1.5 The role of regulation
4.1.6 Future trends
4.1.7 Surgical and non-surgical training
4.1.7.1 Surgical training
4.1.7.2 Non-surgical training
4.1.8 The impact of outbound medical tourism on the UK market
4.2
4.2.9 Otoplasty
4.2.10 Brow lift
4.3 Research conclusions
4.3.1 Trends across the last year
4.3.2 Counties and regions
4.3.3 Devices used
4.3.4 Procedures rising or falling in search volume
5. MAJOR PROVIDERS
5.1 Provider profiles
5.1.1 Aspen Healthcare
5.1.2 BMI Healthcare
5.1.3 The Harley Medical Group
5.1.4 HCA
5.1.5 MYA Cosmetic Surgery
5.1.6 Nuffield Health
5.1.7 The Private Clinic
5.1.8 Ramsay Health Care UK
5.1.9 sk:n (SK:N and Destination Skin)
5.1.10 Spire Healthcare
5.1.11 The Transform Hospital Group
5.2 Relevance and value of brands
6. INVESTORS
6.1 Private equity backed consolidation is accelerating
6.2 Aurelius and The Transform Hospital Group (fka Combine OpCo Limited (Transform and The Hospital Group))
6.3 BlueGem Capital Partners and The Private Clinic Group (PCG)
6.4 RCapital Partners and The Harley Medical Group
6.5 TriSpan and sk:n
6.6 MYA Clinics and John Ryan
7. MARKET POTENTIAL
COSMETIC DENTISTRY
1. MARKET
1.1 Definition
1.2 Market value
1.3 Demand drivers
1.4 Buying behaviour and demography
2. REGULATION
2.1 The consumer and patient perspective
3. PAYORS
3.1 Internet searches for cosmetic dentistry procedures
3.1.1 Teeth whitening
3.1.2 Dental implants
3.1.3 Veneers
3.1.4 Braces
3.1.5 Gum treatment (including laser sculpting)
3.2 Researchconclusions
3.3 Marketing and the role of the media
3.4 Cosmetic dentistry tourism
4. MAJOR PROVIDERS
4.1 Overview
4.2 Operating and investment models
4.2.1 Performance information
5. INVESTORS
5.1 Upwardstrend
5.2 Market movements and consolidation
6. MARKET POTENTIAL
6.1 Technologyand techniques
6.2 Recruitment and training
6.3 Costs of equipment
6.4 Pricing
APPENDICES
APPENDIX 1. GLOSSARY
APPENDIX 2. REGULATORS
APPENDIX 3. TRADE BODIES
APPENDIX 4. COSMETIC SURGERY PRICING SURVEY
APPENDIX 5. BIBLIOGRAPHY
APPENDIX 6. FINANCIAL APPENDIX
Samples
LOADING...
